Together, these data demonstrate a novel role of Shp2 in adipocyte differentiation and support the hypothesis that Shp2 could be a therapeutic target for the control of obesity. This evidence concerns the gene PTPN11 and obesity due to melanocortin 4 receptor deficiency.